Showing results (91-100 of 254) with videos related to

Sort By:
Pageof 26
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 17, 2020
Clinical symptoms and biomarkers of Bermuda grass-induced allergic rhinitis using the nasal allergen challenge modelMatthew Rawls, Jenny Thiele, Daniel E Adams, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2020
Multidisciplinary Real-World Experience With Bilastine, a Second Generation AntihistamineCharles W. Lynde, Gordon Sussman, Pierre-Luc Dion, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 3, 2013
A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitisAnne K Ellis, Yifei Zhu, Lisa M Steacy, et al.
Current Allergy and Asthma Reports|July 2, 2015
Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis ResearchMichelle L North, Mena Soliman, Terry Walker, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 7, 2026
Low risk of ocular toxicity following topical ocular administration of epinephrine nasal spray: implications for unintentional exposureAnne K Ellis, David M Fleischer, Carlos A Camargo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 18, 2023
Anaphylaxis: A 2023 practice parameter updateDavid B K Golden, Julie Wang, Susan Waserman, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 20, 2015
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitisHarold Kim, Susan Waserman, Jacques Hébert, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2009
Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactionsKatherine Arias, Moiz Baig, Marc Colangelo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 12, 2025
ALERT (ChAracterizing uncontroLled sevERe asThma in Canada): Oral corticosteroid and short-acting β<sub>2</sub>-agonist overuseAndréanne Côté, Jeffrey Beach, Jenna Reynolds, et al.
Lancet (London, England)|April 30, 2019
Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safetyDerek K Chu, Robert A Wood, Shannon French, et al.
Pageof 26